Search results
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
10 months ago
Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.ESC Congress 2025 Hot Line Trials Discussed:00:25 DOUBLE-CHOICE03:03 VANTAGE05:03 VICTOR06:28 VICTORIA07:58 DIGIT HF10:19 DAPA ACT HF-TIMI…
View more
Carolyn Lam
Research Area(s) / Expertise:
Author
Expertise
Heart FailurePrevention & Chronic ConditionsGuidelines & StatementsHeart Failure ComorbiditiesDiabetesCardiovascular Kidney MetabolicAtrial FibrillationCoronary Artery DiseaseStrokeAnticoagulationChronic Heart Failure ManagementElectrophysiology & ArrhythmiaHeart Failure Services, Prevention and Digital HealthHFpEF Pharmacological ManagementMedication Optimisation and TitrationHFrEF Pharmacological ManagementHeart Failure Diagnosis and Imaging
JoAnn Lindenfeld
Research Area(s) / Expertise:
Author
Expertise
Heart FailurePrevention & Chronic ConditionsGuidelines & StatementsHeart Failure ComorbiditiesDiabetesCardiovascular Kidney MetabolicAtrial FibrillationCoronary Artery DiseaseStrokeAnticoagulationChronic Heart Failure ManagementElectrophysiology & ArrhythmiaHeart Failure Services, Prevention and Digital HealthHFpEF Pharmacological ManagementMedication Optimisation and TitrationHFrEF Pharmacological ManagementHeart Failure Diagnosis and Imaging
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
Join renowned interventional cardiologists Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) for an exclusive preview of ACC.25's most significant late-breaking science.This episode of View from the Thoraxcenter delivers authoritative analysis of pivotal cardiovascular trials set to revolutionize clinical practice and research. Elevate your conference…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
10 months ago
ESC Congress 2025 - The opening day of ESC Congress 2025 delivered compelling new developments as updated clinical practice guidelines were released alongside a series of eagerly awaited Hot Line trials.Leading interventional cardiologists, Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) present focused overviews of the most significant Hot Line and Late…
View more
Michelle Kittleson
Research Area(s) / Expertise:
Job title: Cardiologist & Professor of Medicine
Author
Kenneth McDonald
Research Area(s) / Expertise:
Author
Expertise
Heart FailurePrevention & Chronic ConditionsGuidelines & StatementsHeart Failure ComorbiditiesDiabetesCardiovascular Kidney MetabolicAtrial FibrillationCoronary Artery DiseaseStrokeAnticoagulationChronic Heart Failure ManagementElectrophysiology & ArrhythmiaHeart Failure Services, Prevention and Digital HealthHFpEF Pharmacological ManagementMedication Optimisation and TitrationHFrEF Pharmacological ManagementHeart Failure Diagnosis and Imaging
Predicting Right Ventricular Failure after LVAD Implantation
Author(s):
Parth Visrodia
,
Aniket S Rali
,
Gabriel Hernandez
,
et al
Added:
8 months ago
Original Research
Lars H Lund
Research Area(s) / Expertise:
Author
Expertise
Heart FailurePrevention & Chronic ConditionsGuidelines & StatementsHeart Failure ComorbiditiesDiabetesCardiovascular Kidney MetabolicAtrial FibrillationCoronary Artery DiseaseStrokeAnticoagulationChronic Heart Failure ManagementElectrophysiology & ArrhythmiaHeart Failure Services, Prevention and Digital HealthHFpEF Pharmacological ManagementMedication Optimisation and TitrationHFrEF Pharmacological ManagementHeart Failure Diagnosis and Imaging
Added:
7 months ago
Source:
Radcliffe Cardiology
A new post hoc analysis of the SUMMIT trial suggests the HFpEF-ABA score is a more effective and inclusive enrichment tool than natriuretic peptide (NP) levels for clinical trials in patients with obesity-related heart failure with preserved ejection fraction (HFpEF).¹ The findings indicate the score, which is based on age, body mass index (BMI), and history of atrial fibrillation (AF), can…
View more